摘要
目的探讨依那普利联合吲达帕胺治疗高血压的临床疗效。方法收集我院2013年1月至2014年3月收治的60例高血压患者资料,将患者按随机数字表法分为试验组和对照组,各30例,对照组患者给予依那普利治疗,试验组患者在其基础上联合吲达帕胺治疗。比较两组患者的临床疗效。结果试验组患者治疗总有效率为93.3%,明显高于对照组的80.0%,且不良反应发生率也低于对照组,差异均有统计学意义(均P<0.05)。结论依那普利联合吲达帕胺治疗高血压患者具有良好的疗效。
Objective To investigate the clinical efficacy of enalapril and indapamide in treatment of essential hypertension.Methods Choose 60 cases of hypertension patients in our hospital from 2013 January to 2014 March were as the object of study, the patients were randomly divided into experimental group and control group,each 30 cases,patients in control group were treated with enalapril treatment,patients in experimental group on the basis of combined with indapamide in the treatment.Comparison of two groups of patients with clinical efficacy.Results In the test group the total effective rate was 93.3%,significantly higher than 80.0% in the control group,and the incidence of adverse events was tower than that of the control group,the difference was statistically significant(P〈0.05). Conclusion Have a good curative effect of enalapril and indapamide in the treatment of patients with hypertension.
出处
《中国药物经济学》
2015年第5期85-86,共2页
China Journal of Pharmaceutical Economics